Study guide
1.4 Medication Safety, Cost Containment & Care-Setting Selection
Board-Certified Case Manager CCM
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Care Management Foundations & Assessment
1.1 The Case Management Process & Core Frameworks 1.2 Comprehensive Patient Assessment & Acuity Stratification 1.3 Individualized Care Planning & Goal Setting 1.4 Medication Safety, Cost Containment & Care-Setting Selection
2 Chapter 2: Care Coordination & Transitions of Care
2.1 Interdisciplinary Care Coordination & Team Collaboration 2.2 Care Transitions & Safe Discharge Planning 2.3 Cross-Setting Communication & Readmission Prevention
3 Chapter 3: Healthcare Reimbursement Systems & Payer Models
3.1 Medicare Coverage, Rules & Statutory Requirements 3.2 Medicaid Programs, Eligibility & State-Federal Regulations 3.3 Commercial Insurance, Managed Care & Utilization Management 3.4 Military, Veterans' & Government Benefit Programs
4 Chapter 4: Value-Based Care & Coding Methodologies
4.1 Value-Based Reimbursement, ACOs & Bundled Payments 4.2 Healthcare Coding Systems (ICD-10, CPT, DRGs) 4.3 Revenue Cycle Management & Financial Advocacy
5 Chapter 5: Psychosocial Assessment & Behavioral Health
5.1 Behavioral Health Screening & Mental Health Disorders 5.2 Substance Use Disorders & Co-Occurring Conditions 5.3 Crisis Intervention & Suicide Risk Management 5.4 Trauma-Informed Care, Abuse & Neglect Screening
6 Chapter 6: Social Determinants, Culture & Support Systems
6.1 Social Determinants of Health (SDOH) & Community Resources 6.2 Cultural Competency, Health Literacy & Communication 6.3 Family Dynamics, Caregiver Support & Support Systems 6.4 Counseling Theories, Stages of Change & Motivational Interviewing 6.5 Supportive Care, Gender Health & Wellness Promotion
7 Chapter 7: Quality Improvement, Safety & Outcomes
7.1 Healthcare Quality Metrics & Performance Improvement (PDSA/RCA) 7.2 Patient Safety, Risk Management & Sentinel Events 7.3 Outcome Measurement, Benchmarking & Accreditation Standards 7.4 Healthcare Data Analytics, Cost-Benefit Analysis & Value-Based Care Impact
8 Chapter 8: Post-Acute Care & Rehabilitation Concepts
8.1 Continuum of Post-Acute Care Settings (SNF, LTACH, IRF) 8.2 Rehabilitation Strategies & Functional Assessments 8.3 Disability Management, Return-to-Work & Assistive Technology
9 Chapter 9: Ethical, Legal & Professional Practice Standards
9.1 The Commission Code of Professional Conduct & Ethical Decision-Making 9.2 Healthcare Law, HIPAA, Confidentiality & Informed Consent 9.3 Patient Advocacy, Scope of Practice & Legal Guardianship 9.4 Documentation Standards, Case Summaries & Regulatory Compliance
1.4 Medication Safety, Cost Containment & Care-Setting Selection
Key Takeaways Explain This Topic AI
Medication reconciliation at every transition, polypharmacy review (≥5 agents), and the AGS Beers Criteria are core case-manager tools for preventing adverse drug events in older adults.
High-alert medications (anticoagulants, insulin, opioids) demand dose verification, duplicate-therapy checks, and patient teach-back before discharge.
Cost containment in case management combines generic substitution, formulary adherence, prior-authorization optimization, and diversion of avoidable emergency and inpatient utilization.
Selecting the correct care setting is an acuity-driven decision: the least-restrictive environment that safely meets the patient's clinical, functional, and reimbursement profile.
Financial toxicity from medication copays drives non-adherence; case managers close the gap via manufacturer assistance, $4 generic programs, and mail-order alignment.
Last updated: July 2026
1.4 Medication Safety, Cost Containment & Care-Setting Selection
Medication management and cost containment are tightly linked responsibilities for the certified case manager. A patient who cannot afford or safely manage a discharge medication regimen will return to the emergency department within days, regardless of how well the inpatient stay was executed. The CCM exam expects candidates to reconcile medications across transitions, recognize high-risk drugs and inappropriate prescribing in older adults, deploy cost-containment levers, and match patients to the least-restrictive setting that their acuity and coverage support.
Medication Reconciliation & Polypharmacy
Medication reconciliation is the formal comparison of a patient's complete medication list against every new order at each transition of care—admission, transfer, and discharge. The case manager verifies that each drug, dose, route, and frequency is intentional. Reconciliation failures are a leading cause of post-discharge adverse drug events.
Polypharmacy is generally defined as concurrent use of five or more medications. It multiplies drug-drug interaction risk, falls, cognitive impairment, and non-adherence.
High-alert medications warrant extra scrutiny: anticoagulants (warfarin, DOACs), insulin , opioids , hypoglycemics , and digoxin . Confirm dose, duplicate therapy, renal dosing, and antidote availability (e.g., naloxone for opioids on discharge).
The AGS Beers Criteria
The American Geriatrics Society Beers Criteria catalog potentially inappropriate medications for adults 65 and older . Common Beers-flagged agents include first-generation antihistamines (diphenhydramine), benzodiazepines, long-acting sulfonylureas (glyburide), and NSAIDs in patients with heart failure or CKD. The case manager flags these for prescriber review rather than independently changing orders—staying within scope of practice.
CCM Exam Trap : A social-worker case manager may identify a suspected Beers-list drug and educate the patient, but may not independently adjust a dose or discontinue a medication. RN case managers may reconcile and educate but still require prescriber sign-off for changes.
Cost-Containment Strategies
Cost containment in case management is the disciplined reduction of unnecessary, duplicative, or avoidable expenditure without compromising safety.
Strategy Mechanism Case-Manager Action
Generic substitution Therapeutically equivalent agents at lower cost Confirm generic availability, mail-order $4/$10 tiers, switch from brand-only PPIs/statins where clinically appropriate.
Formulary adherence Payer-preferred drug tiers minimize copays Route prescribing to tier-1 formulary alternatives; initiate step-therapy documentation when required.
Prior-authorization optimization Expensive therapies need payer approval Submit complete clinical justification upfront to avoid delayed starts and denials.
Avoidable-utilization diversion ED and inpatient days for manageable issues Connect patients to urgent care, PCP, telehealth, and disease management to prevent avoidable admissions.
Readmission prevention Post-discharge follow-up reduces 30-day returns Schedule PCP visit within 7 days, medication reconciliation, and home health for high-risk discharges.
Financial Toxicity & Medication Access
Financial toxicity describes the harm patients suffer when out-of-pocket medication costs force rationing, skipping, or abandoning therapy. Case managers counter it with manufacturer patient-assistance programs (PAPs), nonprofit copay foundations, $4 generic programs at major pharmacies, and mail-order 90-day fills that lower per-dose cost. Verifying medication affordability is part of discharge readiness, not an afterthought.
Selecting the Appropriate Care Setting
Setting selection is an acuity-driven decision: the patient goes to the least-restrictive environment that can safely meet clinical, functional, and reimbursement requirements. Over-placing (home when skilled care is needed) causes readmission; under-placing (SNF when home health suffices) wastes resources and exposes the patient to institutional hazards.
Setting Appropriate When Key Coverage Note
Home health Homebound, skilled need (skilled nursing/PT/OT/ST) Medicare Part A; requires face-to-face encounter within 90 days prior.
Skilled nursing facility (SNF) Post-acute skilled need after 3-day inpatient stay Medicare Part A up to 100 days (100% days 1-20, copay days 21-100).
Inpatient rehab facility (IRF) Intensive rehab, ≥15 hrs/week, 2 disciplines, physician supervision Requires reasonable expectation of functional improvement.
Long-term acute care (LTACH) Medically complex, ≥25 day anticipated stay, vent/weaning Separate DRG payment under Medicare.
Hospice Terminal prognosis ≤6 months if disease runs normal course Waives curative treatment for the terminal diagnosis; palliative care may run concurrently.
Decision Anchor: Function, Not Just Diagnosis
A patient with the same diagnosis may go home with home health, to a SNF, or to an IRF depending on functional status, caregiver support, home safety, and coverage. The Katz ADL and Lawton IADL scores (Section 1.2), caregiver availability, and fall-risk assessment drive the choice as much as the medical diagnosis itself.
Clinical Scenario in Action
Patient Profile : Robert, 78, is discharged after a hip ORIF. His discharge regimen adds an opioid, a DOAC, and a PPI to his pre-existing list of eight medications (now eleven total). His fixed income cannot absorb a $45 brand DOAC copay.
Case-Manager Interventions :
Reconciliation : Confirm all eleven drugs are intentional; flag the brand PPI as a Beers-listed agent and request a tier-1 alternative.
High-alert review : Verify DOAC renal dosing (eGFR 42) and arrange naloxone with the opioid prescription.
Cost containment : Switch the brand DOAC to a covered generic under the formulary and enroll Robert in a manufacturer copay program, lowering out-of-pocket cost to $4.
Setting selection : Robert lives alone, cannot yet transfer safely, and has no caregiver → SNF for skilled rehab until he meets home-discharge criteria, rather than discharging home prematurely.